Polyoxometalates Ameliorate Metabolic Dysfunction-Associated Steatotic Liver Disease by Activating the AMPK Signaling Pathway
These findings suggest that POM is a promising therapeutic strategy with high efficacy in multiple MASLD models.
Authors
- Ke Gong (ORCID: https://orcid.org/0000-0003-0337-297X)
- Yajun Duan (ORCID: https://orcid.org/0000-0002-3880-9070)
- Zequn Yin
- Zhengbao Zha (ORCID: https://orcid.org/0000-0003-3646-4969)
- Jingguo Wang (ORCID: https://orcid.org/0000-0001-9527-3359)
- Shuang Zhang (ORCID: https://orcid.org/0000-0001-6045-4934)
- Dandan Wang (ORCID: https://orcid.org/0000-0002-5626-8968)
Institutions
- University of Science and Technology of China (CN)
- Guiyang Medical University (CN)
- Hefei University of Technology (CN)
- Anhui University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/ijn.s485084
- Citations
- 2
- Primary Topic
- Biochemical Acid Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.59